JINNENG(SH:603113)2022-04-25 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥4,518,480,229.84, representing a year-on-year increase of 75.55%[6] - The net profit attributable to shareholders was ¥124,132,088.74, showing a decrease of 73.88% compared to the same period last year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥96,644,480.35, down 78.22% year-on-year[6] - Basic earnings per share were ¥0.15, a decrease of 73.21% year-on-year[6] - Diluted earnings per share were ¥0.13, down 74.00% compared to the same period last year[6] - The net profit for Q1 2022 was CNY 124,132,088.74, a decrease of 73.8% compared to CNY 475,230,037.48 in Q1 2021[30] - The total profit for Q1 2022 was CNY 150,766,599.15, down from CNY 561,352,529.35 in Q1 2021, reflecting a decline of 73.2%[30] - The total comprehensive income for Q1 2022 was CNY 124,132,088.74, consistent with the net profit figure[32] Revenue and Costs - The total operating revenue for Q1 2022 was CNY 4,518,480,229.84, a significant increase from CNY 2,573,913,177.40 in Q1 2021, representing a growth of approximately 75.5%[26] - The total operating costs for Q1 2022 amounted to CNY 4,426,130,450.40, compared to CNY 2,043,681,676.91 in Q1 2021, reflecting an increase of about 116.5%[26] - The increase in operating revenue was primarily driven by the launch of the Jineng Chemical project, which contributed additional product revenue[12] Cash Flow and Investments - The net cash flow from operating activities was ¥919,460,157.15, an increase of 48.82% compared to the previous year[6] - The net cash flow from operating activities increased to CNY 919,460,157.15, compared to CNY 617,816,604.46 in Q1 2021, representing a growth of 48.8%[35] - The company reported a cash inflow from investment activities of CNY 1,039,192,807.00, while cash outflow was CNY 1,918,033,875.94, resulting in a net cash flow from investment activities of CNY -878,841,068.94[35] Assets and Liabilities - The total assets at the end of the reporting period were ¥14,453,414,827.11, an increase of 10.14% from the end of the previous year[6] - The total current assets as of March 31, 2022, were CNY 6,192,734,789.23, compared to CNY 5,060,463,800.73 at the end of 2021, showing an increase of about 22.3%[22] - The total liabilities as of March 31, 2022, were CNY 5,575,545,438.41, up from CNY 4,369,553,680.40 in the previous year, representing an increase of approximately 27.6%[25] - The total assets as of March 31, 2022, reached CNY 14,453,414,827.11, compared to CNY 13,122,752,671.39 at the end of 2021, reflecting a growth of about 10.1%[27] Shareholder Equity - The equity attributable to shareholders was ¥8,877,869,388.70, reflecting a 1.42% increase from the end of the previous year[6] - The company’s equity attributable to shareholders increased to CNY 8,877,869,388.70 as of March 31, 2022, from CNY 8,753,198,990.99 in the previous year, reflecting a growth of approximately 1.4%[27] Research and Development - Research and development expenses in Q1 2022 were CNY 98,665,981.60, up from CNY 17,850,137.34 in Q1 2021, indicating a growth of approximately 438.5%[26] Employee Compensation - The company reported a decrease in employee compensation liabilities from CNY 68,498,271.94 in Q1 2021 to CNY 55,520,366.09 in Q1 2022, a reduction of about 19%[25] Cash and Cash Equivalents - The cash and cash equivalents as of March 31, 2022, were CNY 1,612,604,432.79, compared to CNY 945,928,242.16 in the previous year, indicating an increase of approximately 70.6%[22] - The cash and cash equivalents at the end of Q1 2022 amounted to CNY 1,465,827,845.10, compared to CNY 573,694,858.56 at the end of Q1 2021, indicating a significant increase[35] Non-Recurring Gains - The company reported non-recurring gains of ¥13,109,230.86 from government subsidies closely related to normal business operations[10] Other Comprehensive Income - The company experienced a decrease in other comprehensive income, with a net amount of CNY 3,882.64 reported[30]